RLLYEli Lilly Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
Eli Lilly is a global pharmaceutical company with core franchises in diabetes, obesity, oncology, immunology, neuroscience and rare diseases. Market attention is centered on its GLP-1/GIP metabolic-drug portfolio, while pipeline progress, manufacturing capacity expansion and pricing/reimbursement policy remain key long-term variables.
- Macro context: RLLY is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
—
14D
+13.03%
30D
—
1Y
—
All-time
+23.33%
Key facts
via /coins/{id}Market Cap Rank
#8101
Circulating Supply
28.38
Total Supply
28.38
All-Time High
$1,445.47 · 2026-10-30
Categories
News & Insights
Also tokenized by
Eli Lilly Tokenized Stock (Reality) is issued as 9 separate tokens across different issuers.
| Issuer | Token | Price | Market Cap | 24h Volume | Networks |
|---|---|---|---|---|---|
| Ondo Finance | $1,413.18 | $8.04M | $3.12M | ||
| xStocks | $1,429.37 | $1.3M | $31.17K | ||
| BTech Holdings Limited | $1,403.66 | $934.19K | $1.01M | ||
| Robinhood Assets (Jersey) Limited | $1,406.06 | $836.76K | $215.46K | ||
| Backpack Securities | $1,403.8 | $333.48K | $399.45K |
Alerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RLLY crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RLLY — the second it drops.
Daily summary
A once-a-day digest of RLLY's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RLLY — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RLLY paired with the latest issuer, regulatory and market news.